CRNC
Cerence Inc.
CRNC trails on the overall score without a compensating advantage in the available component scores.
NVDA
NVIDIA Corporation
NVDA has the edge over CRNC overall, supported by stronger valuation and stronger modeled upside.
CRNC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Strong | |
| Strong |
CRNC's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
CRNC PE Valuation
CRNC has no meaningful PE right now: it lost money over the past year.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
CRNC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Decline | |
| Decline | |
| Stable | |
| Limited | |
| High |
Analysts expect CRNC's earnings and revenue to decline, though with profitability holding steady.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
CRNC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.82 | — |
| Q2 2026 | -$0.31 | +$0.35 |
| Q1 2026 | -$0.40 | +$7.70 |
| Q4 2025 | $0.02 | +$15.24 |
| Q3 2025 | -$0.43 | +$13.69 |
| Q2 2025 | -$0.66 | +$13.26 |
| Q1 2025 | -$8.10 | -$1.27 |
| Q4 2024 | -$15.22 | -$14.40 |
| Q3 2024 | -$14.12 | -$12.72 |
CRNC is still losing money, but far less than before: $0.31 per share over the past year, against $15.22 at its worst in late 2024.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over CRNC on earnings quality, reporting a profit while its opponent remains loss making.
CRNC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $69.6M | +12% |
| Q1 2026 | $64.2M | -18% |
| Q4 2025 | $115.1M | +126% |
| Q3 2025 | $60.6M | +11% |
| Q2 2025 | $62.2M | -12% |
| Q1 2025 | $78M | +15% |
| Q4 2024 | $50.9M | -63% |
| Q3 2024 | $54.8M | -32% |
CRNC's revenue is recovering but still below its 2023 peak: $70M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 2.7% | +4.2 points |
| Q1 2026 | -3.8% | -26 points |
| Q4 2025 | 25% | +59 points |
| Q3 2025 | -2.9% | +32 points |
| Q2 2025 | -1.5% | +502 points |
| Q1 2025 | 22% | +412 points |
| Q4 2024 | -33% | -76 points |
| Q3 2024 | -35% | -40 points |
CRNC's operating margin was 2.7% last quarter, up 4.2 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over CRNC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over CRNC on profitability, with a higher operating margin.
CRNC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $19.6M | +22% |
| Q1 2026 | $13.6M | +3.8% |
| Q4 2025 | $35.6M | +352% |
| Q3 2025 | $9.7M | +109% |
| Q2 2025 | $16.1M | +33% |
| Q1 2025 | $13.1M | +$13.9M |
| Q4 2024 | $7.9M | +$11.6M |
| Q3 2024 | $4.7M | -52% |
CRNC generated $79M in free cash flow over the past year, up 88% from the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA's free cash flow has been positive every quarter for six years: $127B over the past year, up 76% from the year before.
CRNC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.8% | +845K shares |
| 1 year | +10% | +4.5M shares |
| 3 years | +18% | +7.4M shares |
| 5 years | +21% | +8.4M shares |
| Available history | +31% | +11.4M shares |
CRNC has 48M diluted shares, up 10% from a year ago, despite $8M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q2 2026 | $52,000 |
| Q1 2026 | $13,000 |
| Q4 2025 | $7.5M |
| Q3 2025 | $180,000 |
| Q2 2025 | $29,000 |
| Q1 2025 | $802,000 |
| Q4 2024 | $1.4M |
| Q3 2024 | $8,000 |
CRNC spent $8M buying back its own shares over the past year, about four times what it spent the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over CRNC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
CRNC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2019 | 0.0x | Very low |
CRNC has more cash than debt.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
CRNC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.5 | Neutral |
| Stochastic | 31.1 | Neutral |
CRNC's weekly RSI is 45 (neutral) and its Stochastic is 31 (neutral).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
CRNC PE vs Technology Sector
| Metric | CRNC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CRNC has no meaningful PE right now: it lost money over the past year.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
CRNC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.27 | 1.3% below |
| 20 week MA | $8.62 | 5.3% below |
| 50 week MA | $9.28 | 12% below |
| 100 week MA | $9.87 | 17% below |
| 200 week MA | $12.9 | 37% below |
CRNC is in a downtrend: it's below all five of its weekly moving averages, and 37% below its 200-week average.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has the edge over CRNC on trend strength, trading above more of its moving averages.
CRNC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.0 | $105.1 | +401% |
| 2021 | $105.1 | $78.9 | -25% |
| 2022 | $78.9 | $18.6 | -76% |
| 2023 | $18.6 | $19.7 | +5.9% |
| 2024 | $19.7 | $8.49 | -57% |
| 2025 | $8.49 | $11.1 | +30% |
| 2026 YTD | $11.1 | $8.16 | -26% |
CRNC's yearly returns have swung widely, from +401% in 2020 to −76% in 2022. It's down 26% so far in 2026.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over CRNC on returns for 2026, with the stronger performance.